FULC (fulcrumtx.com) Earnings per share growth this year

Official company branding of Fulcrum Corp (FULC)

Fulcrum Therapeutics (FULC) dynamics rely on the FulcrumSeek platform, which blocks damaged genes to treat incurable pathologies. The annual relative change in EPS visualizes this process, where the 49.80 metric determines this level. Diversification into hematology and myology reduces risks, while the development of breakthrough drugs in the trial stage forms the company's long-term growth cycle.

FULC (fulcrumtx.com) Earnings per share growth in current year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for fulcrumtx.com (FULC)

- stock value and consensus price forecast:
Basic company analysis:Fulcrum Corp (FULC)
Manufactured products of Fulcrum Therapeutics

For the science-driven Fulcrum Therapeutics (FULC), which retains geneticists through RSUs, the year-over-year change in EPS reflects the efficiency of capitalizing on early-stage research. This indicator measures the percentage change in net income per share, allowing investors to assess the resilience of the company's fundamental metrics against market shocks and general capital outflow trends.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year XERS (Xeris Biopharma)|KROS: Earnings growth in current year|Arcturus Therapeutics Inc (ARCT) - Earnings growth in current year|Earnings per share growth in current year Eton Pharma|KMDA: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics, Inc. (ABEO)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc